Geode Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
12,588
-2,713
-18% -$60.9K ﹤0.01% 3802
2026
Q1
$345K Sell
15,301
-37,419
-71% -$860K ﹤0.01% 3711
2025
Q4
$1.26M Sell
52,720
-5,185
-9% -$129K ﹤0.01% 3312
2025
Q3
$1.52M Hold
57,905
﹤0.01% 3272
2025
Q2
$1.65M Sell
57,905
-15,473
-21% -$415K ﹤0.01% 3190
2025
Q1
$1.83M Sell
73,378
-17,372
-19% -$414K ﹤0.01% 3071
2024
Q4
$2.05M Hold
90,750
﹤0.01% 3110
2024
Q3
$1.93M Sell
90,750
-3,088
-3% -$60.8K ﹤0.01% 3141
2024
Q2
$1.79M Hold
93,838
﹤0.01% 3150
2024
Q1
$1.81M Hold
93,838
﹤0.01% 3148
2023
Q4
$1.95M Hold
93,838
﹤0.01% 3108
2023
Q3
$2.02M Hold
93,838
﹤0.01% 3073
2023
Q2
$2.25M Sell
93,838
-2,691
-3% -$61.7K ﹤0.01% 3073
2023
Q1
$2.05M Hold
96,529
﹤0.01% 3017
2022
Q4
$1.58M Sell
96,529
-16,179
-14% -$240K ﹤0.01% 3151
2022
Q3
$1.58M Hold
112,708
﹤0.01% 3169
2022
Q2
$2.81M Hold
112,708
﹤0.01% 2995
2022
Q1
$3.8M Sell
112,708
-4,502
-4% -$148K ﹤0.01% 2947
2021
Q4
$3.8M Sell
117,210
-10,715
-8% -$353K ﹤0.01% 3042
2021
Q3
$4.47M Buy
127,925
+5,372
+4% +$210K ﹤0.01% 2968
2021
Q2
$5.09M Sell
122,553
-15,511
-11% -$620K ﹤0.01% 2896
2021
Q1
$5.09M Buy
138,064
+385
+0.3% +$14.6K ﹤0.01% 2784
2020
Q4
$5.72M Buy
137,679
+38,009
+38% +$1.58M ﹤0.01% 2532
2020
Q3
$4.23M Buy
99,670
+473
+0.5% +$20.4K ﹤0.01% 2493
2020
Q2
$4.29M Sell
99,197
-2,621
-3% -$104K ﹤0.01% 2424
2020
Q1
$3.34M Buy
101,818
+24,595
+32% +$914K ﹤0.01% 2378
2019
Q4
$2.84M Buy
77,223
+37,221
+93% +$1.32M ﹤0.01% 2787
2019
Q3
$1.34M Buy
40,002
+25,836
+182% +$916K ﹤0.01% 3128
2019
Q2
$556K Buy
14,166
+3,187
+29% +$126K ﹤0.01% 3429
2019
Q1
$444K Sell
10,979
-875
-7% -$32.6K ﹤0.01% 3478
2018
Q4
$383K Buy
11,854
+1,367
+13% +$55.2K ﹤0.01% 3470
2018
Q3
$539K Buy
10,487
+627
+6% +$31.4K ﹤0.01% 3435
2018
Q2
$496K Buy
9,860
+1,911
+24% +$96.9K ﹤0.01% 3445
2018
Q1
$406K Sell
7,949
-768
-9% -$41K ﹤0.01% 3469
2017
Q4
$458K Buy
8,717
+1,770
+25% +$87.9K ﹤0.01% 3390
2017
Q3
$339K Hold
6,947
﹤0.01% 3489
2017
Q2
$335K Buy
6,947
+252
+4% +$11.6K ﹤0.01% 3505
2017
Q1
$282K Buy
6,695
+1,093
+20% +$45.2K ﹤0.01% 3529
2016
Q4
$236K Sell
5,602
-1,854
-25% -$75.7K ﹤0.01% 3562
2016
Q3
$326K Buy
7,456
+274
+4% +$12.3K ﹤0.01% 3431
2016
Q2
$312K Sell
7,182
-105
-1% -$4.53K ﹤0.01% 3412
2016
Q1
$321K Buy
7,287
+354
+5% +$15K ﹤0.01% 3442
2015
Q4
$290K Buy
6,933
+292
+4% +$12.3K ﹤0.01% 3523
2015
Q3
$259K Buy
6,641
+89
+1% +$3.62K ﹤0.01% 3556
2015
Q2
$272K Sell
6,552
-1,087
-14% -$46.4K ﹤0.01% 3472
2015
Q1
$316K Buy
7,639
+50
+0.7% +$1.93K ﹤0.01% 3399
2014
Q4
$281K Sell
7,589
-734
-9% -$26.4K ﹤0.01% 3439
2014
Q3
$288K Sell
8,323
-877
-10% -$30.2K ﹤0.01% 3421
2014
Q2
$308K Sell
9,200
-746
-8% -$24.9K ﹤0.01% 3371
2014
Q1
$346K Sell
9,946
-254
-2% -$8.89K ﹤0.01% 3301
2013
Q4
$362K Buy
+10,200
New +$342K ﹤0.01% 3214

Other funds holding FMS

Geode Capital Management's FMS Position: Q2 2026 in Review

Geode Capital Management reduced its Fresenius Medical Care (FMS) stake by 18% in Q2 2026, selling an estimated $60.9K and leaving 12,588 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Geode Capital Management first reported a position in FMS in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.72M in Q4 2020. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Geode Capital Management held 12,588 shares of Fresenius Medical Care worth $285K as of Q2 2026.
  • Geode Capital Management sold 2,713 Fresenius Medical Care shares in Q2 2026, an estimated $60.9K.
  • Fresenius Medical Care made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3802 holding.
  • Geode Capital Management first reported a position in Fresenius Medical Care in Q4 2013 and has held it in 51 quarters since.
  • Geode Capital Management's Fresenius Medical Care position peaked at $5.72M in Q4 2020.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.